DNA-only bioassay for simultaneous detection of proteins and nucleic acids

Testing multiple biomarkers, as opposed to one, has become a preferred approach for diagnosing many heterogeneous diseases, such as cancer and infectious diseases. However, numerous technologies, including gold standard ELISA and PCR, can detect only one type of biomarker, either protein or nucleic...

Descripción completa

Detalles Bibliográficos
Autores principales: Montserrat Pagès, Aida, Safdar, Saba, Ven, Karen, Lammertyn, Jeroen, Spasic, Dragana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Paper in Forefront
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238030/
https://www.ncbi.nlm.nih.gov/pubmed/34184101
http://dx.doi.org/10.1007/s00216-021-03458-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238030/
https://www.ncbi.nlm.nih.gov/pubmed/34184101
http://dx.doi.org/10.1007/s00216-021-03458-6

Ejemplares similares